Variant report
Variant | nsv564910 |
---|---|
Chromosome Location | chr14:65604728-65607752 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17102423 | chr14:65604728-65604729 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
2 | rs150528278 | chr14:65604748-65604749 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183505847 | chr14:65604790-65604791 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562391575 | chr14:65604833-65604834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139531061 | chr14:65604867-65604868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74438116 | chr14:65604925-65604926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17093570 | chr14:65604937-65604938 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs533458628 | chr14:65604982-65604983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112164178 | chr14:65605007-65605008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549507126 | chr14:65605008-65605009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547097001 | chr14:65605013-65605014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570907190 | chr14:65605016-65605017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79313383 | chr14:65605017-65605018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs55969418 | chr14:65605021-65605022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550023860 | chr14:65605029-65605030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548961598 | chr14:65605048-65605049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570105881 | chr14:65605073-65605074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568823113 | chr14:65605079-65605080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537790396 | chr14:65605098-65605099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79414106 | chr14:65605140-65605141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112043677 | chr14:65605150-65605151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4902366 | chr14:65605163-65605164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553847938 | chr14:65605171-65605172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573330973 | chr14:65605184-65605185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187769281 | chr14:65605201-65605202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200813723 | chr14:65605204-65605205 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142636430 | chr14:65605259-65605260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144885929 | chr14:65605282-65605283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147961330 | chr14:65605314-65605315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192691079 | chr14:65605362-65605363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184674734 | chr14:65605382-65605383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546741405 | chr14:65605389-65605390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10873182 | chr14:65605408-65605409 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs55955501 | chr14:65605412-65605413 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs548760648 | chr14:65605448-65605449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11158578 | chr14:65605451-65605452 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs7493525 | chr14:65605476-65605477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113887387 | chr14:65605487-65605488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143779734 | chr14:65605493-65605494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs377325210 | chr14:65605556-65605557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs61987426 | chr14:65605571-65605572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74582002 | chr14:65605572-65605573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568030902 | chr14:65605574-65605575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190129214 | chr14:65605592-65605593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148109958 | chr14:65605595-65605596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10873183 | chr14:65605608-65605609 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs553541434 | chr14:65605647-65605648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567362805 | chr14:65605715-65605716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113413960 | chr14:65605725-65605726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373877203 | chr14:65605815-65605816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 22032731 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17603634 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 17440070 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:65601600-65605400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr14:65604200-65605000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr14:65604400-65604800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr14:65604400-65604800 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr14:65604400-65604800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr14:65604400-65604800 | Enhancers | Colonic Mucosa | Colon |
7 | chr14:65604400-65605000 | Enhancers | HMEC | breast |
8 | chr14:65604400-65605000 | Enhancers | NHEK | skin |
9 | chr14:65604400-65605000 | Enhancers | Osteobl | bone |
10 | chr14:65604400-65605200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr14:65604400-65605200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
12 | chr14:65604400-65605200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
13 | chr14:65604400-65605400 | Enhancers | Fetal Intestine Small | intestine |
14 | chr14:65604600-65604800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr14:65604600-65604800 | Enhancers | HSMMtube | muscle |
16 | chr14:65604600-65605400 | Enhancers | Fetal Intestine Large | intestine |
17 | chr14:65604800-65605200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr14:65604800-65605400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr14:65605000-65609200 | Weak transcription | Osteobl | bone |
20 | chr14:65605400-65608800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
21 | chr14:65605400-65609000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |